Results 291 to 300 of about 158,775 (308)

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

Nature Medicine, 2022
Adriaan A Voors, Christiane Angermann Angermann, John R Teerlink   +2 more
exaly  

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Nature Medicine, 2021
Tina Cascone, William N William, Annikka Weissferdt   +2 more
exaly  

Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Jeff Gershenwald, Richard A Scolyer, Vernon K Sondak   +2 more
exaly  

Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening

Ca-A Cancer Journal for Clinicians, 2017
Robert A Smith, Stacey A Fedewa, Otis W Brawley   +2 more
exaly  

American Cancer Society lung cancer screening guidelines

Ca-A Cancer Journal for Clinicians, 2013
Timothy R Church, Christopher R Flowers, Ya-Chen Tina Shih   +2 more
exaly  

Chemoprevention of Cancer

Ca-A Cancer Journal for Clinicians, 2004
Anne S Tsao
exaly  

Reporting guidelines for clinical trial reports for interventions involving artificial intelligence: the CONSORT-AI extension

Nature Medicine, 2020
Xiaoxuan Liu, David Moher, Melanie Calvert   +2 more
exaly  

Clinical development of novel therapeutics for castration‐resistant prostate cancer

Ca-A Cancer Journal for Clinicians, 2012
Matthew D Galsky, Alexander C Small, William K Oh   +2 more
exaly  

Prevention and Early Detection Clinical Trials: Opportunities for Primary Care Providers and Their Patients

Ca-A Cancer Journal for Clinicians, 2003
Robert A Smith
exaly  

T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial

Nature Medicine, 2020
K J Ewer, Jordan R Barrett, Sandra Belij-Rammerstorfer   +2 more
exaly